Scholars@Duke

NB-TMEC: a non-animal platform to advance CAR-T therapy for high-risk neuroblastoma

Research Grant
Duke Scholars
Nelson Jen An Chao
Collaborator Nelson Jen An Chao Medicine, Hematologic Malignancies and Cellular Therapy
Sharon Gerecht
Investigator Sharon Gerecht Biomedical Engineering
Luigi Racioppi
Principal Investigator Luigi Racioppi Medicine, Hematologic Malignancies and Cellular Therapy
Kris Mahadeo
Collaborator Kris Mahadeo Pediatrics, Transplant and Cellular Therapy

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Alternatives Research & Development Foundation

Start Date

October 1, 2026

End Date

September 30, 2028
 

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Alternatives Research & Development Foundation

Start Date

October 1, 2026

End Date

September 30, 2028